BioSpace News Archive

Fagron Sterile Services is voluntarily recalling two (2) lots of Neostigmine Methylsulfate 5mL syringes to the user/hospital/clinic level.

OVERCOME Aims to be Largest Study of its Kind With 40,000 People with Migraine

The Company will provide a wide range of adult-use brands and products to be sold at licensed retailers across the province

BioTime, Inc. announced that it has been awarded a grant of $743,345 from the Small Business Innovation Research (SBIR) program of the National Institutes of Health (NIH).

Puma Biotechnology, Inc. announced that on June 28, 2018 the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending marketing authorisation for the medicinal product NERLYNX® (neratinib)

First and only PD-1 agent to receive positive CHMP opinion in the adjuvant setting

ITUS Corporation announced that it has been invited by NASDAQ to ring the closing bell on July 5, 2018.

Amneal Pharmaceuticals, Inc. announced that the Company will release its second quarter 2018 financial results on Thursday, August 9, 2018

Ocular Therapeutix ™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, has announced the resubmission of the Company’s New Drug Application to the U.S. Food and Drug Administration...

Jazz Pharmaceuticals plc today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) issued a positive opinion recommending marketing authorisation of Vyxeos™ 44 mg/100 mg powder for concentrate for solution for infusion for the treatment...